Company intelligence / Profile preview

Coffeesai

Ownership: Private
Development stage: Preclinical

Overview

Coffeesai is pioneering the production of real coffee using cellular agriculture. By isolating cells from coffee plant leaves and expanding them in bioreactors with Pluri’s proprietary 3D cell expansion platform, they can produce the equivalent of 1,000 trees’ worth of coffee in just three weeks. The process enables rapid scaling and customization for flavor profiles while dramatically reducing environmental impact compared to traditional farming. The company has demonstrated proof-of-concept and is progressing toward initial commercial sales and regulatory approvals[1][2][3][4].

Modalities: Cell-based agriculture (cellular agriculture)3D cell expansion technology (proprietary)
Industry: Non-Drug Biotech

Partnerships

Seeking business partners for R&D, regulation, production scaling; no major partnerships publicly disclosed yet[4].

Beyond the preview

Go deeper on Coffeesai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coffeesai.

Explore the full profile